In this study there will be no drug intervention. The study will include a Baseline visit and a follow up visit scheduled at Month 4. At these visits medical history, safety assessments, concomitant medications, exercise tests and quality of life questionnaire data will be collected.
The purpose of the study is to collect information on disease characteristics from adult patients diagnosed with fatty acid oxidation disorders.